LBL-003
- Generic Name
- LBL-003
Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2024-05-21
- Lead Sponsor
- Nanjing Leads Biolabs Co.,Ltd
- Target Recruit Count
- 18
- Registration Number
- NCT05042908
- Locations
- 🇨🇳
Henan Cancer Hospital, Zhengzhou, Henan, China
🇨🇳Shangdong Cancer Hospital, Jinan, Shandong, China
🇨🇳Hunan Cancer Hospital, Changsha, Hunan, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath